Inventvacc was founded by Dr. Kapre & Mr. Pradip Ghate in 2016 to develop vaccines for rare diseases currently affecting more than 400 million people worldwide. Our mission and focus is to empower healthy living by developing unique, efficacious and affordable vaccines for the populations most in need. Over the years, the company has grown from a small R&D lab, operating out of Vancouver, Canada, to a multinational commercial operations with an innovative pipeline. InventVacc provides high-quality, cost-effective vaccines. Our global approach not only provides high-quality and innovative products to protect against the world’s deadliest diseases but it also help people address health inequalities and empower people to live healthy lives. We leverage the best of vaccine technology, science and manufacturing to prevent devastating infectious disease.